<p>For each sex and age grouping, these panels show estimated asymptotic CD4+ count versus estimated CD4+ count at treatment initiation, as fitted in the best fit asymptotic non-linear mixed effects regression model of CD4+ counts over time for patients within the outpatient monitoring system of the National AIDS Control Program in Tanzania. Each circle represents one patient. Blue lines show fitted linear regressions with value in bottom right of each panel showing the R<sup>2</sup> for this correlation.</p
ObjectivesThe aim of this work was to provide a reference for the CD4 T-cell count response in the e...
We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably...
Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents d...
Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...
New guidelines recommend that all HIV-infected individuals initiate antiretroviral treatment (ART) i...
BackgroundCD4 cell counts is widely used as a biomarker for treatment progression when studying the ...
OBJECTIVE: New guidelines recommend that all HIV-infected individuals initiate antiretroviral treatm...
OBJECTIVE:New guidelines recommend that all HIV-infected individuals initiate antiretroviral treatme...
Model trajectories of CD4 and CD8 cell counts after starting combination antiretroviral therapy (ART...
<p>A: Median profiles (numbers on top indicate individuals contributing measurements at each time po...
Background. Human immunodeficiency virus (HIV) is a major health problem in the world, and failure t...
Objective: Model trajectories of CD4+ and CD8+ cell counts after starting combination antiretroviral...
The aim of this work was to provide a reference for the CD4 T-cell count response in the early month...
Objective: Model trajectories of CD4+ and CD8+ cell counts after starting combination antiretroviral...
Background: Random effects models were used to explore how the shape of CD4 cell count responses aft...
ObjectivesThe aim of this work was to provide a reference for the CD4 T-cell count response in the e...
We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably...
Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents d...
Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...
New guidelines recommend that all HIV-infected individuals initiate antiretroviral treatment (ART) i...
BackgroundCD4 cell counts is widely used as a biomarker for treatment progression when studying the ...
OBJECTIVE: New guidelines recommend that all HIV-infected individuals initiate antiretroviral treatm...
OBJECTIVE:New guidelines recommend that all HIV-infected individuals initiate antiretroviral treatme...
Model trajectories of CD4 and CD8 cell counts after starting combination antiretroviral therapy (ART...
<p>A: Median profiles (numbers on top indicate individuals contributing measurements at each time po...
Background. Human immunodeficiency virus (HIV) is a major health problem in the world, and failure t...
Objective: Model trajectories of CD4+ and CD8+ cell counts after starting combination antiretroviral...
The aim of this work was to provide a reference for the CD4 T-cell count response in the early month...
Objective: Model trajectories of CD4+ and CD8+ cell counts after starting combination antiretroviral...
Background: Random effects models were used to explore how the shape of CD4 cell count responses aft...
ObjectivesThe aim of this work was to provide a reference for the CD4 T-cell count response in the e...
We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably...
Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents d...